Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients.
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.
Drug uptake transporters in antiretroviral therapy.
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication.
RNA interference as a tool for exploring HIV-1 robustness.